免疫激活对抑郁症谷氨酸和五羟色胺系统的调节
The mediation of immune activation on serotonin and glutamate systems in pathological process of depression
查看参考文献28篇
|
文摘
|
免疫异常与神经递质改变是抑郁症产生的十分重要的因素.近年来,免疫激活产生的细胞因子对抑郁症病理过程的干预作用已成为众多学者研究的热点,亦是新型抗抑郁药的潜在靶点.免疫激活能导致谷氨酸系统和五羟色胺系统的紊乱,该文对此干预作用作一综述. |
|
其他语种文摘
|
Immunological alterations and changes in neurotransmission are considered to be crucial in the pathological process of depression. An immune activation including increased production of proinflammatory cytokines has repeatedly been described in depression, which shines a clue for new anti-depression therapy. Immune activation will lead to depression through serotonin and glutamate systems. This paper is attempted to review the immune mediated alterations on serotonin and glutamate systems. |
|
来源
|
中国药理学通报
,2009,25(12):1555-1558 【核心库】
|
|
关键词
|
抑郁症
;
谷氨酸
;
五羟色胺
;
免疫激活
;
细胞因子
;
吲哚胺2,3-二氧化酶
|
|
地址
|
1.
浙江大学药物安全评价研究中心, 浙江, 杭州, 310058
2.
中国科学院心理研究所, 心理健康院重点实验室, 北京, 100101
|
|
语种
|
中文 |
|
文献类型
|
综述型 |
|
ISSN
|
1001-1978 |
|
学科
|
医药、卫生;基础医学;神经病学与精神病学;药学 |
|
基金
|
中国科学院心理研究所青年基金
|
|
文献收藏号
|
CSCD:3786004
|
参考文献 共
28
共2页
|
|
1.
薛瑞. 快速起效抗抑郁药物的研究进展.
中国药理学通报,2006,24(12):1558-1561
|
CSCD被引
2
次
|
|
|
|
|
2.
Xue R. Progress in the development of early-onset antidepressants.
Chinese Pharmacological Bulletin,2008,24(12):1558-1561
|
CSCD被引
1
次
|
|
|
|
|
3.
Basterzi A D. IL-6 levels decrease with SSRI treatment in patients with major depression.
Human Psychopharmacology,2005,20(7):473-476
|
CSCD被引
5
次
|
|
|
|
|
4.
Tuglu C. Increased serum tumor necrosis factor-alpha levels and treatment response in major depressive disorder.
PSYCHOPHARMACOLOGY,2003,170(4):429-433
|
CSCD被引
10
次
|
|
|
|
|
5.
Myint A M. Th1,Th2,and Th3 cytokine Alterations in major depression.
Journal of affective disorders,2005,88(2):167-173
|
CSCD被引
13
次
|
|
|
|
|
6.
Tsao C W. Cytokines and serotonin transporter in patients with major depression.
Progress in neuro-Psychopharmacology & Biological Psychiatry,2006,30(5):899-905
|
CSCD被引
12
次
|
|
|
|
|
7.
Raison C L. Cytokines sing the blues:inflammation and the pathogenesis of depression.
Trends in Immunology,2006,27(1):24-31
|
CSCD被引
52
次
|
|
|
|
|
8.
Maes M. Depressive and anxiety symptoms in the early puerperium are related to increased degradation of tryptophan into kynurenine,a phenomenon which is related to immune activation.
Life Sciences,2002,71(16):1837-1848
|
CSCD被引
5
次
|
|
|
|
|
9.
Schaefer M. Correlation between sICAM-1 and depressive symptoms during adjuvant treatment of melanoma with interferon-alpha.
Brain Behavior and Immunity,2004,18(6):555-562
|
CSCD被引
2
次
|
|
|
|
|
10.
Anisman H. Neurotransmitter,peptide and cytokine processes in relation to depressive disorder:Comorbidity between depression and neurodegenerative disorders.
Progress in Neurobiology,2008,85(1):1-74
|
CSCD被引
14
次
|
|
|
|
|
11.
Felger J C. Effects of interferon-alpha on rhesus monkeys:A non-human primate model of cytokine-induced depression.
Biological Psychiatry,2007,62(11):1324-1333
|
CSCD被引
6
次
|
|
|
|
|
12.
Asnis G M. IFN-induced depression:a role for NSAIDs.
Psychopharmacology Bulletin,2003,37(3):29-50
|
CSCD被引
2
次
|
|
|
|
|
13.
Merali Z. Bombesin receptors as novel anti-anxiety therapeutic target;non-peptide antagonist PD 176252 reduces anxiety and 5-HT release through BB1 receptor.
Journal of Neuroscience,2006,26(41):10387-10396
|
CSCD被引
2
次
|
|
|
|
|
14.
Capuron L. Interferonalpha-induced changes in tryptophan metabolism:Relationship to depression and paroxetine treatment.
Biological Psychiatry,2003,54(9):906-914
|
CSCD被引
6
次
|
|
|
|
|
15.
O′Connor J C. Lipopolysaccharide-induced depressive-like behavior is mediated by indoleamine 2,3-dioxygenase activation in mice.
Molecular Psychiatry,2008,14(5):511-522
|
CSCD被引
1
次
|
|
|
|
|
16.
Braun D. A two-step induction of indoleamine 2,3 dioxygenase(IDO)activity during dendritic-cell maturation.
Blood,2005,106(7):2375-2381
|
CSCD被引
7
次
|
|
|
|
|
17.
Wichers M C. The role of indoleamine 2,3-dioxygenase(IDO)in the pathophysiology of interferon-α-induced depression.
JOURNAL OF PSYCHIATRY & NEUROSCIENCE,2004,29(1):11-17
|
CSCD被引
7
次
|
|
|
|
|
18.
Hardy J. The amyloid hypothesis of Alzheimer′s disease:progress and problems on the road to therapeutics.
SCIENCE,2002,297(5580):353-356
|
CSCD被引
449
次
|
|
|
|
|
19.
Sanchez M M. Activated p38 MAPK is associated with decreased CSF 5-HIAA and increased maternal rejection during infancy in rhesusmonkeys.
Molecular Psychiatry,2007,12(10):895-897
|
CSCD被引
1
次
|
|
|
|
|
20.
Miller A H. Mechanisms of cytokine-induced behavioral changes:Psychoneuroimmunology at the translational interface.
Brain Behavior and Immunity,2008,23(2):149-158
|
CSCD被引
1
次
|
|
|
|
|
了解气象卫星更多信息，请访问